Table 5. Number of NIPMSs fulfilling each of the marketing indicators.

Marketing indicator	Number (%) of NIPMSs*
Remuneration was inappropriate or not clearly warranted	10 (41.7%)**
Drug has been on the market for too long	8 (33.3%)
Low scientific quality	10 (41.7%)
Low formal quality	5 (20.8%)
Negligible effort required by physician	1 (4.2%)
Required report missing	7 (29.1%)
Contract contains a secrecy clause	13 (54.2%)

Marketing indicators described in [9] and S4 Appendix.

*NIPMSs fulfilling the characteristics; n = 24.

**Not appropriate, 4 (16.7%); unclear whether appropriate, 6 (25.0%).

NIPMS, non-interventional post-marketing study.